Peptron
Daily close in US$ at the latest USD/KRW close. Source: KRX via FinanceDataReader.
Peptron develops medicines that stay active in the body for longer than conventional drugs, using peptide engineering and sustained-release technology to reduce how often patients need a dose.
It operates in the drug-development and pharmaceutical manufacturing space, targeting both clinical-stage and commercial products. Listed on KOSDAQ, Korea's tech and small-cap board, the company has built its own GMP-certified large-scale production facility capable of supplying both clinical-trial materials and commercially launched drugs.
Summary is AI-generated and may contain errors · figures from DART filings
Peptron in five facts
What does Peptron do?
Peptron develops medicines that stay active in the body for longer than conventional drugs, using peptide engineering and sustained-release technology to reduce how often patients need a dose.
Where is Peptron listed and in which sector?
Peptron (Korean name: 펩트론) trades under KRX code 087010 on KOSDAQ, the Korea Exchange's board for smaller and growth companies. It is classified in the Health Care sector, Pharmaceuticals.
How large is Peptron?
Its market capitalisation was US$1.9B on 2026-10-21, which puts it in this site's large-cap group. US$ amounts are converted from won at 1 USD ≈ ₩1,325 (2026-10-21).
What were Peptron's latest annual revenue and operating profit?
For fiscal year 2025, Peptron reported revenue of US$4.3M, an operating loss of US$16M and a net loss of US$10.4M, per its annual report on DART (data retrieved from DART on 2026-09-17). Revenue was up 78.8% on the previous year.
Where does this data come from?
Financial statements and filings come from DART, Korea's official corporate-filing system. Share prices, market capitalisation and trading status come from KRX. Company summaries are AI-generated from the filings and may contain errors; financial figures are mapped directly from DART.
Data sources and last updated
- Filings and financial statements
- DART (dart.fss.or.kr), Korea's official corporate-filing system
- Prices, market cap, trading status
- KRX (Korea Exchange), via FinanceDataReader
- Latest annual financials
- Fiscal year 2025, data retrieved from DART on 2026-09-17
- Share price and market cap
- Close of 2026-10-21
- Currency
- US$, converted from won at 1 USD ≈ ₩1,325 (2026-10-21 close)
- Company data updated
- 2026-10-21
- Company summary
- AI-generated from filings; may contain errors. Information only, not investment advice.